Together we will beat cancer

Donate now

Jacob Smith

Jacob is a digital news officer at Cancer Research UK. He studied biochemistry at the University of Exeter and subsequently completed a Master’s in science communication at Imperial College London. He joined the digital news team in March 2022, writing for the news site and contributing to our podcast, That Cancer Conversation.
Jacob Smith
Showing 12 out of 49 results
An image of a chest x-ray showing some signs of disease

Up to 14% of people with lung cancer in the UK have never smoked. New research funded by us reveals why non-smokers face delays in getting diagnosed with lung cancer Up to 14% of people with lung cancer in the UK have never smoked. New research funded by us reveals why non-smokers face delays in getting diagnosed with lung cancer

by Jacob Smith | In depth | 25 November 2022

25 November 2022

T cell

Researchers in Southampton have found a way to improve the effectiveness of immunotherapy in cancers that are resistant by repurposing existing drugs Researchers in Southampton have found a way to improve the effectiveness of immunotherapy in cancers that are resistant by repurposing existing drugs

by Jacob Smith | Analysis | 11 November 2022

11 November 2022

The House of Parliament in London

Research from the International Cancer Benchmarking Partnership has found a link between cancer policy consistency over time and survival for six cancer types Research from the International Cancer Benchmarking Partnership has found a link between cancer policy consistency over time and survival for six cancer types

by Jacob Smith | Analysis | 1 November 2022

1 November 2022

A 3D illustration of cancer cells

Research from our Cambridge Institute has shown us that metastasis isn’t a process unique to cancer, revolutionising the way we think about cell dissemination.  Research from our Cambridge Institute has shown us that metastasis isn’t a process unique to cancer, revolutionising the way we think about cell dissemination. 

by Jacob Smith | Analysis | 18 October 2022

18 October 2022

A graphic depicting a shadow in the shape of DNA overlaying strings of genetic code

A team of researchers has developed a new tool to identify mutational signatures in cancer DNA that's quickly establishing itself as the best of the best.   A team of researchers has developed a new tool to identify mutational signatures in cancer DNA that's quickly establishing itself as the best of the best.  

by Jacob Smith | Analysis | 12 October 2022

12 October 2022

A prostate cancer cell.

NICE does not recommend olaparib (Lynparza) for people with a type of advanced prostate cancer, as the treatment is not deemed cost-effective NICE does not recommend olaparib (Lynparza) for people with a type of advanced prostate cancer, as the treatment is not deemed cost-effective

by Jacob Smith | News | 13 September 2022

13 September 2022

A illustration of T cells, a type of immune cell attacking cancer

If we’re to reduce the risk of bowel cancer in people with IBD, we’re going to have to find a more effective treatment. And we may have done just that.  If we’re to reduce the risk of bowel cancer in people with IBD, we’re going to have to find a more effective treatment. And we may have done just that. 

by Jacob Smith | Analysis | 23 August 2022

23 August 2022

A woman sat on a sofa looking into the distance

A poll has revealed 50% of UK adults with a possible cancer symptom wait 6 months or more before contacting their GP. Why might people not seek help when they need it? A poll has revealed 50% of UK adults with a possible cancer symptom wait 6 months or more before contacting their GP. Why might people not seek help when they need it?

by Jacob Smith | In depth | 10 August 2022

10 August 2022

The faecal immunochemical test kit used for bowel cancer screening in the UK

If we can find interventions that help to increase participation in screening programmes amongst lower income groups, we may be able to reduce the health inequalities that exist in bowel cancer outcomes.   If we can find interventions that help to increase participation in screening programmes amongst lower income groups, we may be able to reduce the health inequalities that exist in bowel cancer outcomes.  

by Jacob Smith | Analysis | 5 July 2022

5 July 2022